Correlation Between Synmosa Biopharma and TTY Biopharm

Can any of the company-specific risk be diversified away by investing in both Synmosa Biopharma and TTY Biopharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Synmosa Biopharma and TTY Biopharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Synmosa Biopharma and TTY Biopharm Co, you can compare the effects of market volatilities on Synmosa Biopharma and TTY Biopharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Synmosa Biopharma with a short position of TTY Biopharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Synmosa Biopharma and TTY Biopharm.

Diversification Opportunities for Synmosa Biopharma and TTY Biopharm

-0.18

Correlation Coefficient

Synmosa Biopharma  TTY Biopharm

Good diversification

The 3 months correlation between Synmosa and TTY is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Synmosa Biopharma and TTY Biopharm Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TTY Biopharm and Synmosa Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Synmosa Biopharma are associated (or correlated) with TTY Biopharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TTY Biopharm has no effect on the direction of Synmosa Biopharma i.e., Synmosa Biopharma and TTY Biopharm go up and down completely randomly.

Pair Corralation between Synmosa Biopharma and TTY Biopharm

Assuming the 90 days trading horizon Synmosa Biopharma is expected to under-perform the TTY Biopharm. In addition to that, Synmosa Biopharma is 2.18 times more volatile than TTY Biopharm Co. It trades about -0.13 of its total potential returns per unit of risk. TTY Biopharm Co is currently generating about 0.08 per unit of volatility. If you would invest  7,380  in TTY Biopharm Co on October 20, 2024 and sell it today you would earn a total of  190.00  from holding TTY Biopharm Co or generate 2.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Synmosa Biopharma  vs.  TTY Biopharm Co

Synmosa Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Synmosa Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

TTY Biopharm

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in TTY Biopharm Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, TTY Biopharm is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Synmosa Biopharma and TTY Biopharm

The main advantage of trading using opposite Synmosa Biopharma and TTY Biopharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Synmosa Biopharma position performs unexpectedly, TTY Biopharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TTY Biopharm will offset losses from the drop in TTY Biopharm's long position.

The idea behind Synmosa Biopharma and TTY Biopharm Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.